PLK1 also phosphorylates MRE11 on S649, and prostate cancer cells (U2OS) expressing phosphomimetic MRE11 have a 5-fold increased sensitivity to olaparib, both in vitro and in vivo [40]. Here, PLK1 is linked to prostate carcinoma.